Euforbium Compositum Nazentropfen S spray 20 ml.


Manufacturer: Germany

Rhinitis of various origins (viral, bacterial, allergic) and types (vasomotor, dry, hyperplastic and atrophic). Acute and chronic sinusitis. Ozena (as an additional tool).



Euforbium Compositum Storage
active substances: 100 g of the drug contain: Argentum nitricum D10 – 1 g, Euphorbium D4 – 1 g, Hepar sulfuris D10 – 1 g, Hydrargyrum biiodatum D8 – 1 g, Luffa operculata D2 – 1 g, Mucosa nasalis suis D8 – 1 g, Pulsatilla pratensis D2 – 1 g, Sinusitis Nosode D13 – 1 g;

Excipients: benzalkonium chloride solution, sodium hydrogen phosphate dihydrate, sodium chloride, sodium dihydrogen phosphate dihydrate, purified water.

Euforbium Compositum Dosage form
Nasal spray.

Main physical and chemical properties: from transparent to slightly opalescent, from colorless to slightly light yellow solution, odor neutral.

Pharmacotherapeutic group
Complex homeopathic remedy.

Pharmacological properties


The drug has anti-edematous, anti-inflammatory, antiviral, immunocorrective and anti-allergic effects, based on the activation of the body’s defenses and normalization of impaired functions due to substances of plant, mineral and animal origin, which are part of the drug.

Euforbium Compositum Indication
Rhinitis of various origins (viral, bacterial, allergic) and types (vasomotor, dry, hyperplastic and atrophic). Acute and chronic sinusitis. Ozen (as an additional tool).

Hypersensitivity to benzalkonium chloride and to other components of the drug.

Interaction with other medicinal products and other forms of interaction
The drug is compatible with other drugs.

Features of application
In the first few days of drug use, a short-term increase in nasal secretion is sometimes possible, which is a good sign and does not require discontinuation of treatment.

If symptoms persist or worsen, consult a physician.

Use during pregnancy or breastfeeding
Due to the lack of proper documented experience, the question of the appropriateness of the drug during pregnancy or breastfeeding is decided by the doctor individually, taking into account the benefit-risk ratio.

Ability to influence the speed of reaction when driving a car or working with other mechanisms
Cases of exposure are unknown.

Method of application and dosage
Single dose: adults and children over 6 years – 1-2 injections in each nostril 3-5 times a day; children aged 2 to 6 years – 1 injection 3-4 times a day.

Course of treatment: 2-6 weeks.